Physician profile
Eric Sean Bohn
NPI 1700826690
$5,710.32
in general payments reported to CMS, 2019-2025
34 companies · $1,525 in 2025
The $1,525 reported for 2025 was more than what 93% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $389 · 2021: $456 · 2022: $667 · 2023: $893 · 2024: $994 · 2025: $1,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,412.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,102.11 | 2022-2025 | Rinvoq |
| Amgen INC. | $882.90 | 2019-2025 | Otezla, Enbrel, Evenity |
| Janssen Biotech, INC. | $766.45 | 2022-2025 | Tremfya, Simponi Aria |
| Ucb, INC. | $476.13 | 2019-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $413.24 | 2019-2024 | |
| Antares Pharma, INC. | $222.65 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Lilly USA, LLC | $182.55 | 2021-2025 | Taltz, Zepbound |
| Mallinckrodt Enterprises LLC | $180.93 | 2019 | |
| Sobi, INC | $151.78 | 2021-2025 | |
| Glaxosmithkline, LLC. | $119.49 | 2020-2021 | |
| Organon LLC | $114.65 | 2024-2025 | Hadlima, Renflexis |
| Bioventus LLC | $108.45 | 2019-2025 | Durolane, Durolane |
| Trice Medical, INC. | $98.28 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $92.89 | 2022-2023 | Saphnelo |
| Electronic Waveform Lab, INC. | $73.82 | 2023-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $68.16 | 2019-2020 | |
| Fresenius Kabi USA, LLC | $58.68 | 2024-2025 | Idacio |
| Si-Bone, INC. | $58.27 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $57.93 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $57.90 | 2020 | |
| Pacira Therapeutics, INC. | $49.93 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $45.28 | 2025 | |
| Ani Pharmaceuticals, INC. | $43.86 | 2025 | Purified Cortrophin Gel |
| Kiniksa Pharmaceuticals International, Plc | $42.37 | 2024 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $38.97 | 2019-2021 | |
| Halozyme INC | $37.11 | 2023 | |
| Ferring Pharmaceuticals INC. | $30.86 | 2023-2025 | Euflexxa |
| Spr Therapeutics, INC | $27.37 | 2025 | Sprint Pns System |
| Celgene Corporation | $26.72 | 2019 | |
| Abbott Laboratories | $24.33 | 2022 | |
| Pfizer INC. | $16.29 | 2019 | |
| Smith+Nephew, INC. | $14.13 | 2019 | |
| Orthofix Medical, INC. | $13.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.